Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rüdiger Heicappell is active.

Publication


Featured researches published by Rüdiger Heicappell.


The Journal of Pathology | 2002

Methylation‐specific PCR for detection of neoplastic DNA in biopsy washings

Carsten Goessl; Markus Müller; Rüdiger Heicappell; Hans Krause; Martin Schostak; Bernd Straub; Kurt Miller

Epigenetic DNA alterations such as promoter hypermethylation of glutathione S‐transferase P1 (GSTP1) in prostatic adenocarcinoma frequently constitute tumour biomarkers. Neoplastic transformation was identified in washings of prostate biopsies by GSTP1 promoter hypermethylation, using methylation‐specific PCR (MSP). Twenty‐six patients undergoing sextant transrectal prostate biopsies for clinically suspected prostate cancer were enrolled. All ten patients diagnosed with adenocarcinoma (100%) and four of six patients with prostatic intraepithelial neoplasia (67%), but none of ten patients with benign hyperplasia (0%), exhibited GSTP1 promoter hypermethylation in at least one out of six biopsy washings. Since this approach is transferable to various cancer entities, a sensitive and specific DNA‐based analysis of biopsy material seems generally feasible without impeding routine histopathological examination. Copyright


European Urology Supplements | 2002

Molecular staging of surgical margins after radical prostatectomy by detection of telomerase activity

Bernd Straub; Markus Müller; Carsten Goessl; Mark Schrader; Rüdiger Heicappell; Kurt Miller

BACKGROUNDnThe further course of prostate cancer (PC) after radical prostatectomy (RPX) is decisively influenced by the local tumor stage. Although it is thus far possible to assess the risk of local recurrence from the pathohistology, precise predictions cannot be made. A more precise evaluation would be desirable, mainly for early planning of adjuvant therapy. Other authors have shown that telomerase activity may be a marker for malignant potential. We assessed the detection of telomerase activity using the telomeric repeat amplification protocol (TRAP) in surgical margins compared to conventional histopathological examination.nnnMETHODSnNinety-two patients with local PC who underwent RPX were examined. After RPX biopsies were obtained from four defined areas of the prostatic fossa and processed by TRAP assay for telomerase activity using a standard protocol.nnnRESULTSnIn 5 of 48 patients (10.4%) with organ-confined prostate carcinoma (pT2) telomerase activity could be detected. Seven of 47 patients (14.9%) with locally advanced PC (> pT2) had at least one positive specimen.nnnCONCLUSIONSnThe results obtained in our study indicate that detection of telomerase activity by TRAP assay may be a suitable parameter for molecular staging of surgical margins, because of the high tumor-specificity. Further follow-up must clarify whether patients with positive molecular detection have an increased risk of local recurrence.


Cancer Research | 1998

Microsatellite Analysis of Plasma DNA from Patients with Clear Cell Renal Carcinoma

Carsten Goessl; Rüdiger Heicappell; Ralf Münker; Philippe Anker; Maurice Stroun; Hans Krause; Markus Müller; Kurt Miller


Clinical Cancer Research | 1998

Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.

Markus Müller; Hans Krause; Rüdiger Heicappell; Jens Tischendorf; Jerry W. Shay; Kurt Miller


Clinical Cancer Research | 2001

Increased Incidence of Luteinizing Hormone-releasing Hormone Receptor Gene Messenger RNA Expression in Hormone-refractory Human Prostate Cancers

Bernd Straub; Markus Müller; Hans Krause; Mark Schrader; Carsten Goessl; Rüdiger Heicappell; Kurt Miller


Cancer Research | 2001

Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.

Jana Sachsinger; Eva González-Suárez; Enrique Samper; Rüdiger Heicappell; Markus Müller; Maria A. Blasco


Oncology Reports | 2002

Molecular staging of pelvic surgical margins after radical prostatectomy: Comparison of RT-PCR for prostate-specific antigen and telomerase activity

Bernd Straub; Markus Müller; Hans Krause; Carsten Goessl; Mark Schrader; Rüdiger Heicappell; Kurt Miller


The Journal of Urology | 1999

DIAGNOSIS OF BLADDER CANCER BY DETECTING DIFFERENT TELOMERASE-SUBUNITS IN URINE

Markus Müller; Rüdiger Heicappell; Hans Krause; Anja Dankof; Kurt Miller


European Urology Supplements | 2002

Quantification of cyclin A1 expression in testicular tissue of infertile patients

Mark Schrader; C. Müller; Markus Müller; Rüdiger Heicappell; Bernd Straub; Kurt Miller


European Urology Supplements | 2002

Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and TUR-P using “light—cycler”—based quantitative real-time PCR

Bernd Straub; Markus Müller; Carsten Goessl; Mark Schrader; Rüdiger Heicappell; Kurt Miller

Collaboration


Dive into the Rüdiger Heicappell's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Markus Müller

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bernd Straub

Free University of Berlin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jana Sachsinger

Free University of Berlin

View shared research outputs
Top Co-Authors

Avatar

Markus Müller

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Martin Schostak

Otto-von-Guericke University Magdeburg

View shared research outputs
Researchain Logo
Decentralizing Knowledge